Palisade Bio (PALI)

• Market cap: $248M
• 1 day: -1.19%
• 5 days: -16.58%
• 1 month: -13.09%
• 3 months: 66%
• 6 months: 98.85%
• Year to date: -10.75%
• 1 year: -34.9%
• 5 years: -99.93%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Employees: 8